DIPROPHOS susp inj ser usage unique 1 ml

7680395280459 CH-39528 H02AB01 07.07.25
DIPROPHOS susp inj ser usage unique 1 ml
DIPROPHOS susp inj ser usage unique 1 ml
DIPROPHOS susp inj ser usage unique 1 ml
1 / 3
google

Details

Product number
3952803
CPT
-
Packaging group
1 x 1 ml
Unit
Fertigspritze(n)
Composition
betamethasonum 5 mg ut betamethasoni dipropionas, betamethasonum 2 mg ut betamethasoni natrii phosphas, dinatrii phosphas dihydricus, natrii chloridum, dinatrii edetas, polysorbatum 80, carmellosum natricum, macrogolum 3350, conserv.: propylis parahydroxybenzoas 0.2 mg, E 218 1.3 mg, alcohol benzylicus 9 mg, aqua ad iniectabile q.s. ad suspensionem pro 1 ml.

Articles (1)

Diprophos, Injektionssuspension (Fertigspritze)
Injektionssuspension
1 x 1 ml
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/03/2026
Professional SmPC
Français
18/03/2026

Detailed composition

Substance Quantity Type Category
betamethasonum
5.0 MG Substance Wirkstoff (Principe actif)
betamethasoni dipropionas
- Substance WIZUS
betamethasonum
2.0 MG Substance Wirkstoff (Principe actif)
betamethasoni natrii phosphas
- Substance WIZUS
dinatrii phosphas dihydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
alcohol benzylicus
9.0 MG Substance HBESI
E 218
1.3 MG Substance HBESI
macrogolum 3350
- Substance HNIDK
propylis parahydroxybenzoas
0.2 MG Substance HBESI
carmellosum natricum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Organon GmbH

6006 Luzern

Authorization information

Swissmedic authorization number
39528
Drug name
Diprophos, Injektionssuspension
Galenic form
SUPA
ATC Code
H02AB01
Authorization status
Z
Dispensation category
B
First authorization
30/03/1976
Authorization expiration date
31/12/9999
IT number
07.07.25
Domain
Human medicine
Field of application
Intramuskuläre und lokale Glukokortikosteroid-Therapie

Packaging details

Description (FR)
DIPROPHOS susp inj ser usage unique 1 ml
Description (DE)
DIPROPHOS Inj Susp Einwegspr 1 ml
Market launch
30/03/1976
Market withdrawal
10/03/2026
Narcotic (BTM)
No

Other packaging sizes

DIPROPHOS susp inj amp 1 ml
1 x 1 ml AMP
View
DIPROPHOS susp inj 5 amp 1 ml
5 x 1 ml AMP
View
Buy us a coffee Explore the data